JPWO2021066175A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021066175A5
JPWO2021066175A5 JP2021551622A JP2021551622A JPWO2021066175A5 JP WO2021066175 A5 JPWO2021066175 A5 JP WO2021066175A5 JP 2021551622 A JP2021551622 A JP 2021551622A JP 2021551622 A JP2021551622 A JP 2021551622A JP WO2021066175 A5 JPWO2021066175 A5 JP WO2021066175A5
Authority
JP
Japan
Prior art keywords
delivery system
active pharmaceutical
conjugate
hydrophobic compound
pharmaceutical ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021551622A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021066175A1 (cg-RX-API-DMAC7.html
JP7660066B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/037640 external-priority patent/WO2021066175A1/ja
Publication of JPWO2021066175A1 publication Critical patent/JPWO2021066175A1/ja
Publication of JPWO2021066175A5 publication Critical patent/JPWO2021066175A5/ja
Priority to JP2025059920A priority Critical patent/JP2025094276A/ja
Application granted granted Critical
Publication of JP7660066B2 publication Critical patent/JP7660066B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021551622A 2019-10-03 2020-10-02 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム Active JP7660066B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025059920A JP2025094276A (ja) 2019-10-03 2025-03-31 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019183082 2019-10-03
JP2019183082 2019-10-03
PCT/JP2020/037640 WO2021066175A1 (ja) 2019-10-03 2020-10-02 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025059920A Division JP2025094276A (ja) 2019-10-03 2025-03-31 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤

Publications (3)

Publication Number Publication Date
JPWO2021066175A1 JPWO2021066175A1 (cg-RX-API-DMAC7.html) 2021-04-08
JPWO2021066175A5 true JPWO2021066175A5 (cg-RX-API-DMAC7.html) 2023-10-02
JP7660066B2 JP7660066B2 (ja) 2025-04-10

Family

ID=75338281

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021551622A Active JP7660066B2 (ja) 2019-10-03 2020-10-02 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム
JP2025059920A Pending JP2025094276A (ja) 2019-10-03 2025-03-31 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025059920A Pending JP2025094276A (ja) 2019-10-03 2025-03-31 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム、医薬組成物、及び膀胱疾患処置剤

Country Status (4)

Country Link
US (1) US20220370630A1 (cg-RX-API-DMAC7.html)
EP (1) EP4039279A4 (cg-RX-API-DMAC7.html)
JP (2) JP7660066B2 (cg-RX-API-DMAC7.html)
WO (1) WO2021066175A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023034903A1 (en) * 2021-09-01 2023-03-09 3Helix, Inc. Systems and methods for detecting fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US20080306022A1 (en) 2005-10-12 2008-12-11 Kenji Miyamoto Agent for Applying to Mucosa and Method for the Production Thereof
US10098962B2 (en) * 2013-07-10 2018-10-16 Seikagaku Corporation Glycosaminoglycan derivative and method for producing same
US20150250717A1 (en) * 2014-03-06 2015-09-10 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder cancer with gemcitabine
US10350236B2 (en) * 2015-01-09 2019-07-16 Seikagaku Corporation Chondroitin sulfate derivative and agent for treating bladder diseases
JP7067229B2 (ja) 2018-04-17 2022-05-16 信越化学工業株式会社 反応性ケイ素含有基を有するポリマーおよびその製造方法

Similar Documents

Publication Publication Date Title
JP5349318B2 (ja) ステロイド類の高分子結合体
EP4450487A3 (en) Lipids for lipid nanoparticle delivery of active agents
JP2018524339A5 (cg-RX-API-DMAC7.html)
JP5856069B2 (ja) 新規なシチジン系代謝拮抗剤の高分子誘導体
EP2898881B1 (en) Compositions comprising supramolecular complexes of polyanionic polymers and spermidine for use in the treatment of periodontum and damaged oral tissue
TW201815786A (zh) 苯并咪唑衍生物((S)-4-(5,7-二氟唍-4-基氧基)-N,N,2-三甲基-1H-苯并[d]]咪唑-6-甲醯胺)之酸加成鹽
RU2008126305A (ru) Новый пептид
JP2008543854A5 (cg-RX-API-DMAC7.html)
JP2018531962A5 (cg-RX-API-DMAC7.html)
MXPA02005536A (es) Acidos aminopropilfosfinicos novedosos.
CA2637765A1 (en) Benzamide and heteroarene derivatives
GEP20156209B (en) Linaclotide-containing formulations for oral administration
JPWO2008010463A1 (ja) コンブレタスタチン類の高分子結合体
EE200200245A (et) Farmatseutiline kompositsioon, mis sisaldab tolterodiini ja selle kasutamine
MX2025013218A (es) Lipidos para usarse en formulaciones de nanoparticulas de lipido
JP2021529818A (ja) 治療用デンドリマー
MX2025005209A (es) Compuestos lipídicos y usos de los mismos
CN110612143A (zh) 抗微生物化合物、组合物及其用途
MX2025015196A (es) Amida y éster mixtos que contienen lípidos para usarse en nanopartículas lipídicas
WO2005085294A1 (ja) ヒアルロン酸−メトトレキサート結合体
JP2025118775A5 (cg-RX-API-DMAC7.html)
CN120731082A (zh) 新多功能寡肽
MX2022011242A (es) Inmunomodulación de o-het/aril azálidos.
TW202133882A (zh) 肽與多醣的新共軛物
JP4467888B2 (ja) アロエ−エモジン誘導体と腫瘍性病理学の治療におけるその使用